Quantcast
Home / Opinion / Commentary / Reforming FDA, not price control, is path to cheaper drugs

Reforming FDA, not price control, is path to cheaper drugs

It is easy to see the political allure of “cheap drugs,” but what is often ignored by advocates of market distorting price controls is the long-term impact such policies will have on medical innovation and access.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

x

Check Also

DomesticViolence

What the state is doing to help further victims’ rights

As one of Arizona’s largest funders of victims’ services each year, ACJC places great focus on seeking legislative changes that advocate for victims’ rights, provide additional resources, and improves accessibility to victims’ services and programs.